TUESDAY, Sept. 8, 2026 — The U.S. Food and Drug Administration (FDA) has approved a new daily pill for adults with advanced breast cancer whose tumors have found a way around their current treatment.
The drug, Etcamah (camizestrant), is taken…
Blog
Leave a Reply